Clinical Trial Update: Study on Optimizing the Treatment of Patients With Acute Myeloid Leukemia Based on Early Peripheral Blood Minimal Residual Disease [Phase 2]

View source ↗

Summary

This update describes a Phase 2 clinical trial aiming to optimize AML treatment based on early peripheral blood minimal residual disease status, and it is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Yehui Tan | Conditions: Acute Myeloid Leukemia (AML) | Phase 2 | Status: RECRUITING